Activist Group Rejects Settlement, Raises Stake to 17.41%, and Sets July 31 Deadline for Board Overhaul
EVGN sits 51% above its 52-week low of $0.37.
Summary
The activist group demanding a board overhaul at Evogene rejected a settlement offer, bought more shares to reach 17.41% ownership, and set a July 31 deadline for the company to call a special meeting — intensifying the proxy battle.
Key Events · Ownership and Investor Activity · EVGN
-
Settlement Rejected, Deadlines Set
The activist group rejected the board's offer of a single seat and demanded the special meeting be called by July 31, 2026, with the meeting held by September 4, 2026. It also requested draft proxy materials by July 28.
-
Stake Increased to 17.41%
Pure Capital bought 80,000 ADSs at $0.579 on July 20, 2026, raising the group's aggregate ownership to 2,308,100 shares (17.41% of outstanding).
-
Warning Against Extraordinary Actions
The group warned the board not to take any actions outside the ordinary course of business before the special meeting, citing potential conflicts of interest.
-
Proxy Fight Intensifies
This is the third 13D filing in 17 days, showing an escalating activist campaign against a backdrop of a $3.3M ATM offering and a terminated Bayer partnership.
Analysis · EVGN · Industrial Applications And Services
The activist group seeking to replace Evogene's board has escalated its campaign. It rejected the company's settlement offer of a single board seat, demanded the board call a special meeting by July 31, and warned against any extraordinary corporate actions before then. The group also bought 80,000 more shares, lifting its stake to 17.41%. This hardens the proxy fight and raises the stakes for the upcoming special meeting, which could reshape the company's strategy amid a cash crunch and ongoing ATM dilution.
At the time of this filing, EVGN was trading at $0.56 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $6.6M. The 52-week trading range was $0.37 to $1.50. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.